Recurrent ESBL-producing Enterobacteriaceae Bacteremia: Risk Factor, Molecular Character and Susceptibility Change
1 other identifier
observational
400
1 country
1
Brief Summary
The purpose of this study is to investigate the risk factor, molecular character and susceptibility change for recurrent ESBL-producing Enterobacteriaceae bacteremia
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 10, 2011
CompletedFirst Posted
Study publicly available on registry
July 12, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2012
CompletedJuly 12, 2011
January 1, 2011
July 10, 2011
July 11, 2011
Conditions
Eligibility Criteria
In a tertiary care hospital, every adult patient with at least one episode of ESBL-EK bloodstream infection from August 2004 to July 2010 will be recruited into this study. Patients who died within 48h after first episode of ESBL-EK bloodstream infection will be excluded.
You may qualify if:
- Adult patients (age\>=18 years) with at least one episode of ESBL-EK bloodstream infection from August 2004 to July 2010
You may not qualify if:
- Patients who died within 48h after first episode of ESBL-EK bloodstream infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chang Gung Memorial Hospitallead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
Chang Gung Medical Foundation, Kaohsiung Branch
Kaohsiung City, Taiwan
Biospecimen
ESBL strains of E. coli or K. pneumoniae from blood cultures under normal practice
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Chen-Hsiang Lee, M.D.
Chang Gung Medical Foundation, Kaohsiung Branch
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 10, 2011
First Posted
July 12, 2011
Study Start
July 1, 2011
Study Completion
December 1, 2012
Last Updated
July 12, 2011
Record last verified: 2011-01